KERX Related Earnings News
-
Keryx Biopharmaceuticals, Inc. (KERX) Posts Mixed Q1 Results
-
Brean Reiterates Buy on Keryx Biopharmaceuticals (KERX)
-
Keryx Biopharmaceuticals, Inc. (KERX ) Misses Q4 EPS by 1c
-
Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'
-
Keryx Biopharmaceuticals, Inc. (KERX) Misses Q3 EPS by 1c
-
Keryx Biopharma (KERX) Posts Narrower than Expected Q2 Loss of 2c/Share
-
Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Opportunities for Zerenex
-
Keryx Biopharma (KERX) Reports Q1 Loss of 13c/Share, Misses by 1c
-
Brean Murray Maintains 'Buy' on Keryx (KERX); Focus Shifts to Less Risky Zerenex
-
Keryx Biopharmaceuticals, Inc. (KERX) Tops Q4 EPS by 2c
-
Keryx Biopharmaceuticals, Inc. (KERX) Posts Q3 Loss of $0.15
-
Keryx Biopharmaceuticals (KERX) Posts Q2 Loss of 5c/Share; Revs In-Line
-
Keryx Biopharma (KERX) Posts Q1 Loss of 10c
-
Keryx (KERX) Reports Q4 Loss of 9c, Misses by 3c
-
Keryx Biopharma (KERX) Posts In-Line Q3 Loss of 10c
-
Keryx Biopharma (KERX) Posts Q1 Loss of $0.07, Beats Views
-
Keryx Biopharma (KERX) Reports Q4 Loss of $0.08, Misses by 2c
-
Keryx Biopharma (KERX) Posts Q3 EPS of 1c, Beats by 10c
-
Keryx Biopharmaceuticals (KERX) Swings to Q1 Profit
-
Keryx Biopharmaceuticals (KERX) Tops Q4 EPS by 5c; CEO Comments on Outlook
Back to KERX Stock Lookup
